Immune-inflammatory diseases under your skin

Our aim

We are looking for partners to help us to identify, validate or test new targets for the treatment of chronic immune-inflammatory diseases of the skin.

Psoriasis, atopic dermatitis or pemphigus vulgaris are examples of chronic immune-inflammatory skin diseases associated with significant comorbidities that have a profound impact in the quality of life of patients. They are our focus.

Many chronic immune-inflammatory diseases, irrespective of the organ affected (joints, CNS, gut or skin), share common mechanisms, pathways and players: psoriasis has therapies in common with multiple sclerosis and rheumatoid arthritis; atopic dermatitis with asthma; pemphigus with lupus, to name a few.

Regardless of your field of expertise, if you are a scientist with an idea (target, pathway, therapy) that you think might be of use in a dermatological disease, share it with us and we will explore it, together.

Who is this for

This call is addressed to scientists affiliated to Universities, Research Centers, Start-ups, Biotechs, and Pharma companies.

Collaborative framework

  • Submitted proposals may become eligible to receive a research grant
    • Funding will be granted to those submissions that are deemed valuable and are approved by Almirall
    • Research grant up to € 250000. Final amount will be consistent with the proposed research project, and it may be provided in one or several installments
  • Intellectual property rights remain with the applicant
    • You will retain ownership of any intellectual property you may bring or develop
  • Additional scientific support will be provided on an ad-hoc basis
    • Mentorship by Almirall experts to advance the initial proposal to meet project criteria
    • Technology platforms to assist in your target validation
    • Pharmacological tools
    • Advise on intellectual property matters
  • A designated contact person will help you should you have questions

Collaboration process

  • Proposal submission
    • The first step is for you to create an account on AlmirallShare Innovation platform, which is a secure site to store and manage your proposals
    • The submission period is from July 25th, 2019 to October 31st, 2019
    • Please include an outline of your idea (max. 300 words) and a detailed description of your proposal including publications that support it
    • All the initial information provided under the proposal should be non-confidential
  • Submissions will be handled following all applicable local compliance requirements
    • For Investigator Sponsored Trial (IST) requests from individual healthcare professionals, please submit through the standard local channels
  • Proposal evaluation and selection
    • A team of Almirall scientific experts will evaluate your proposal as soon as it will be received
    • You will receive in writing Almirall’s decision regarding your proposal within 4-8 weeks after submission
    • If your proposal has been selected, a member of the Shared Innovation Team will reach out to you to initiate a collaboration agreement that will reflect the experimental activities supported and the funding amount
    • An Almirall scientist will be assigned to collaborate with you on project definition as well as project follow-up

For scientists at Universities, public and private Research Institutions, Biotechs and Start-ups

Open from 25/07/19 to 04/11/19
Research grants up to € 250000

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our policy of cookies, click on the link for more information.

Aviso de cookies